Chief Executive Officer · TELA Bio, Inc. (TELA)

Antony Koblish

A named executive officer of TELA Bio in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,969,555

Salary $639,467Stock awards $405,280

FY2024: $2,105,341

1st of 3 named executive officers at Tela Bio by FY2025 total.

3 named officers on file for TELA Bio, FY2025

Antony Koblish’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TELA Bio’s whole pay program stands against its peers

  • TELA Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TELA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2026 (DEF 14A).

Free

Get Antony Koblish’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Antony Koblish compensation by year

TELA Bio Summary Compensation Table · all 2 fiscal years held
In US dollars, as TELA Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$617,800$639,467
Stock awards$547,925$405,280
Option awards$547,401$595,680
Non-equity incentive$389,215$326,128
All other$3,000$3,000
Total$2,105,341$1,969,555

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TELA Bio, Inc. DEF 14A filed April 30, 2026, accession 0001104659-26-053117, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TELA Bio, Inc. filed document, accession 0001104659-26-053117. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

$2.1M
$2.0M
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU149,000$175,820—
PSU85,772$101,211—
RSU58,125$68,588—
RSU30,600$36,108—
RSU11,625$13,718—
Option3,313—$11.98
Option28,030—$10.50
Option61,317—$7.07
Option219,000—$2.72

Per the Outstanding Equity Awards at Fiscal Year-End table in TELA Bio, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

TELA Bio’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Antony Koblish · this pageChief Executive Officer$1,969,555
Roberto CucaChief Operating Officer, Chief Financial Officer and Corporate Secretary$1,035,851
Jeffrey BlizardPresident$952,715

The full TELA Bio compensation record

free company brief

This page is one person within TELA Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TELA Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Antony Koblish's compensation dossier · One-time report. No refunds.